Author

F. O. Adeshakin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Assay:metabolomics· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. O. Adeshakin· 1 shared D. Yan· 1 shared G. Zhang· 1 shared L. Lin· 1 shared L. O. Afolabi· 1 shared L. Wang· 1 shared M. Zhang· 1 shared W. Liu· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. O. Adeshakin

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivSep 28, 2020

Regulation of lipid accumulation-induced ROS in myeloid-derived suppressor cells via targeting fatty-acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy

A. O. Adeshakin, W. Liu, F. O. Adeshakin…·X. Wan

This study shows that inhibiting FATP2 in MDSCs reduces ROS and enhances anti-PD-L1 immunotherapy by improving T-cell function and reducing PD-L1 expression.

DOI 10.1016/j.cellimm.2021.104286

mouseproteomics

𝕏 PostBluesky